Acute effects of haemodialysis on pro-/anti-apoptotic genes in peripheral blood leukocytes

Cellular Physiology and Biochemistry

Volumn 22, Issue 5-6, 2008, Pages 423-430

  Friedrich, Björn ^a   Janessa, Andrea ^a   Schmieder, Rebecca ^a   Risler, Teut ^a   Alexander, Dorothea ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Apoptosis; Haemodialysis; Quantitative real time PCR

Indexed keywords

C REACTIVE PROTEIN; CASPASE 5; CASPASE 8; CD40 LIGAND; CELL MARKER; DEATH RECEPTOR 5; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

AGED; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CELL ACTIVATION; CELL ISOLATION; CELL STIMULATION; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIALYSIS MEMBRANE; DNA TRANSCRIPTION; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMMUNOCOMPETENT CELL; KIDNEY DISEASE; KIDNEY FAILURE; LEUKOCYTE; LYMPHOCYTE; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROTEIN FAMILY; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSLATION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

EID: 57649227993     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000185486     Document Type: Article

References (36)

1. Carracedo J, Ramirez R, Madueno JA, Soriano S, Rodriguez-Benot A, Rodriguez M, Martin-Malo A, Aljama P: Cell apoptosis and hemodialysis-induced inflammation. Kidney Int Suppl 2002;89-93.
2. Gulbins E, Jekle A, Ferlinz K, Grassme H, Lang F: Physiology of apoptosis. Am J Physiol Renal Physiol 2000;279:F605-F615.
3. Andrikos E, Buoncristiani E, D'Intini V, Bordoni V, Bonello M, Levin N, Buoncristiani U, Pappas M, Ronco C: Effect of daily hemodialysis on monocytes apoptosis. Blood Purif 2005;23:79-82.
4. de Cal M, Cruz DN, Corradi V, Nalesso F, Polanco N, Lentini P, Brendolan A, Tetta C, Ronco C: HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients. Blood Purif 2008;26:249-254.
5. Bordoni V, Piroddi M, Galli F, de Cal M, Bonello M, Dimitri P, Salvatori G, Ranishta R, Levin N, Tetta C, Ronco C: Oxidant and carbonyl stress-related apoptosis in end-stage kidney disease: impact of membrane flux. Blood Purif 2006;24:149-156.
6. Matsumoto J, Yanagisawa N, Konoma T, Haizuka H, Nakashima Y, Sato M: Increased Fas antigen in uremia accelerates adhesion of mononuclear cells to endothelial and sinovial cells via stimulated hyaluronan production. Am J Kidney Dis 2001;38:S54-S57.
7. Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J, Shapiro G, Hassan K, Shkolnik G, Geron R, Kristal B: Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol 2005;16:2431-2438.
8. Sardenberg C, Suassuna P, Andreoli MC, Watanabe R, Dalboni MA, Manfredi SR, dos Santos OP, Kallas EG, Draibe SA, Cendoroglo M: Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephrol Dial Transplant 2006;21:160-165.
9. Atamaniuk J, Ruzicka K, Stuhlmeier KM, Karimi A, Eigner M, Mueller MM: Cell-free plasma DNA: a marker for apoptosis during hemodialysis. Clin Chem 2006;52:523-526.
10. Koller H, Hochegger K, Zlabinger GJ, Lhotta K, Mayer G, Rosenkranz AR: Apoptosis of human polymorphonuclear neutrophils accelerated by dialysis membranes via the activation of the complement system. Nephrol Dial Transplant 2004;19:3104-3111.
11. Soriano S, Martin-Malo A, Carracedo J, Ramirez R, Rodriguez M, Aljama P: Lymphocyte apoptosis: role of uremia and permeability of dialysis membrane. Nephron Clin Pract 2005;100:c71-c77.
12. Andreoli MC, Dalboni MA, Watanabe R, Manfredi SR, Canziani ME, Kallas EG, Sesso RC, Draibe SA, Balakrishnan VS, Jaber BL, Liangos O, Cendoroglo M: Impact of dialyzer membrane on apoptosis and function of polymorphonuclear cells and cytokine synthesis by peripheral blood mononuclear cells in hemodialysis patients. Artif Organs 2007;31:887-892.
13. Wu CC, Liao TN, Lu KC, Chen JS, Chu P, Lin SH, Chuang CH, Lin YF: Apoptotic markers on lymphocytes and monocytes are unchanged during single hemodialysis sessions using either regenerated cellulose or polysulfone membranes. Clin Nephrol 2005;64:198-204.
14. Martin-Malo A, Carracedo J, Ramirez R, Rodriguez-Benot A, Soriano S, Rodriguez M, Aljama P: Effect of uremia and dialysis modality on mononuclear cell apoptosis. J Am Soc Nephrol 2000;11:936-942.
15. Friedrich B, Alexander D, Janessa A, Haring HU, Lang F, Risler T: Acute effects of hemodialysis on cytokine transcription profiles: evidence for C-reactive protein-dependency of mediator induction. Kidney Int 2006;70:2124-2130.
16. Friedrich B, Alexander D, Aicher WK, Duszenko M, Schaub TP, Passlick-Deetjen J, Waldegger S, Wolf S, Risler T, Lang F: Influence of standard haemodialysis treatment on transcription of human serum- and glucocorticoid-inducible kinase SGK1 and taurine transporter TAUT in blood leukocytes. Nephrol Dial Transplant 2005;20:768-774.
17. Alvarez-Lara MA, Carracedo J, Ramirez R, Martin-Malo A, Rodriguez M, Madueno JA, Aljama P: The imbalance in the ratio of Th1 and Th2 helper lymphocytes in uraemia is mediated by an increased apoptosis of Th1 subset. Nephrol Dial Transplant 2004;19:3084-3090.
18. Raj DS, Boivin MA, Dominic EA, Boyd A, Roy PK, Rihani T, Tzamaloukas AH, Shah VO, Moseley P: Haemodialysis induces mitochondrial dysfunction and apoptosis. Eur J Clin Invest 2007;37:971-977.
19. Cendoroglo M, Jaber BL, Balakrishnan VS, Perianayagam M, King AJ, Pereira BJ: Neutrophil apoptosis and dysfunction in uremia. J Am Soc Nephrol 1999;10:93-100.
20. Jaber BL, Balakrishnan VS, Cendoroglo MN, Perianayagam MC, King AJ, Pereira BJ: Modulation of neutrophil apoptosis by uremic plasma during hemodialysis. Blood Purif 1998;16:325-335.
21. Majewska E, Baj Z, Sulowska Z, Rysz J, Luciak M: Effects of uraemia and haemodialysis on neutrophil apoptosis and expression of apoptosis-related proteins. Nephrol Dial Transplant 2003;18:2582-2588.
22. Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM: Regulation of apoptosis in the immune system. Curr Opin Immunol 1994;6:279-289.
23. Fulda S, Debatin KM: Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene 2006;25:4798-4811.
24. Rowinsky EK: Targeted induction of apoptosis in cancer management: the emerging role of tumor necrosis factor-related apoptosis-inducing ligand receptor activating agents. J Clin Oncol 2005;23:9394-9407.
25. Jaber BL, Perianayagam MC, Balakrishnan VS, King AJ, Pereira BJ: Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system. J Leukoc Biol 2001;69:1006-1012.
26. Matsumoto Y, Shinzato T, Amano I, Takai I, Kimura Y, Morita H, Miwa M, Nakane K, Yoshikai Y, Maeda K: Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: a possible mechanism for lymphopenia in chronic renal failure. Biochem Biophys Res Commun 1995;215:98-105.
27. Ranjan R, Shah H, Siu J, Varghese E, Bhaskaran M, Reddy K, Kapasi AA, Wagner JD, Singhal PC: Monocyte apoptosis in dialysis patients is Fas ligand-mediated. Clin Nephrol 2002;58:423-430.
28. Daoussis D, Andonopoulos AP, Liossis SN: Targeting CD40L: a promising therapeutic approach. Clin Diagn Lab Immunol 2004;11:635-641.
29. Fuleihan R, Ramesh N, Horner A, Ahern D, Belshaw PJ, Alberg DG, Stamenkovic I, Harmon W, Geha RS: Cyclosporin A inhibits CD40 ligand expression in T lymphocytes. J Clin Invest 1994;93:1315-1320.
30. Cho CS, Burkly LC, Fechner JH, Jr., Kirk AD, Oberley TD, Dong Y, Brunner KG, Peters D, Tenhoor CN, Nadeau K, Yagci G, Ishido N, Schultz JM, Tsuchida M, Hamawy MM, Knechtle SJ: Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients. Transplantation 2001;72:587-597.
31. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 1998;391:591-594.
32. Li H, Nord EP: IL-8 amplifies CD40/CD154 mediated ICAM-1 production via the CXCR-1 receptor and p38-MAPK pathway in human renal proximal tubule cells. Am J Physiol Renal Physiol 2008;in press.
33. Loskog A, Totterman TH: CD40L - a multipotent molecule for tumor therapy. Endocr Metab Immune Disord Drug Targets 2007;7:23-28.
34. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM, Huang DC: Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005;17:393-403.
35. Martin-Malo A, Ramirez R, Aljama P: Is bcl-2 a key molecule in the abnormal immune response of hemodialysis patients? Blood Purif 2006;24:540-541.
36. Doong H, Rizzo K, Fang S, Kulpa V, Weissman AM, Kohn EC: CAIR-1/BAG-3 abrogates heat shock protein-70 chaperone complex-mediated protein degradation: accumulation of polyubiquitinated Hsp90 client proteins. J Biol Chem 2003;278:28490-28500.